This may reflect an important role for genes such as DAXX, ATRX, CHEK2, BRCA2, and TP53 in the rare malignant transformation of insulinomas; these genes may also provide clues to genes and pathways that must be avoided in attempts at therapeutic expansion of human beta cells. The gene discussed is CHEK2; the disease is pancreatic insulinoma.